DENPODMA
LIVE

Serial Number

97705136

Owner

TEVA PHARMACEUTICALS USA, Inc.

Attorney

Lori Wolfe

Filing Date

Dec 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DENPODMA Trademark

Serial Number: 97705136

DENPODMA is a trademark filed by TEVA PHARMACEUTICALS USA, Inc. on December 6, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

TEVA PHARMACEUTICALS USA, Inc.

Building A
Parsippany, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

December 6, 2022

Registration Date

Not Registered

Published for Opposition

October 24, 2023

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2026 EXRA
SOU EXTENSION 4 GRANTED
Mar 3, 2026 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 2, 2026 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 23, 2026 TPEX
NOTICE OF REVIVAL - E-MAILED
Jan 23, 2026 NREV
PETITION TO REVIVE-GRANTED
Jan 23, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 23, 2026 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 19, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 19, 2026 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 15, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 15, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 15, 2026 REAP
SOU EXTENSION 4 FILED
Dec 18, 2025 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jun 2, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 2, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2024 EXRA
SOU EXTENSION 2 GRANTED
Dec 5, 2024 EX2G
SOU EXTENSION 2 FILED
Dec 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 18, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 18, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 18, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 18, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2023 CNEA
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2022 NWOS
NEW APPLICATION ENTERED
Dec 9, 2022 NWAP